A National Multicenter Study on Initial Antiviral Treatment Preferences on Chronic Hepatitis B: Entecavir Versus Tenofovir Disoproxil Fumarate

This national multicenter study emphasizes that patient-related factors, including gender, age, baseline renal function, and liver disease severity, significantly influence the choice of first-line antiviral therapy for CHB, often outweighing disease-specific factors. Cite this article as: Yamazhan T, Zerdali E, Önlen Y, et al. A national multicenter study on initial antiviral treatment preferences on chronic hepatitis B: Entecavir versus tenofovir disoproxil fumarate. Turk J Gastroenterol. 2026;37(2):179-185.

Authors

Institutions

Publication Details

Journal
The Turkish Journal of Gastroenterology
Published
2025-10-24
DOI
https://doi.org/10.5152/tjg.2025.24741
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A National Multicenter Study on Initial Antiviral Treatment Preferences on Chronic Hepatitis B: Entecavir Versus Tenofovir Disoproxil Fumarate

Esra Zerdalı, Nurullah Eser, Serhat Uysal, Oğuzhan Acet et al.
The Turkish Journal of Gastroenterology
Hepatitis B Virus Studies
article

A National Multicenter Study on Initial Antiviral Treatment Preferences on Chronic Hepatitis B: Entecavir Versus Tenofovir Disoproxil Fumarate

Esra Zerdalı, Nurullah Eser, Serhat Uysal, Oğuzhan Acet, Yusuf Önlen, Tayibe Bal, Umay Balcı, Rahmet Güner, Sibel Yıldız Kaya, Sevil Alkan, İmran Hasanoğlu, Tuba Turunç, Esma Aslıhan Aydemir, Oğuz Karabay, Selma Tosun, Lütfiye Nilsun Altunal, Fehmı Tabak, Ayşe Batırel, Tansu Yamazhan, Özgür Günal, Ayşe İnci, İlknur Esen Yıldız, Selçuk Kaya, Dilek Sevgi Yıldız, Hacer Deniz Özkaya
article en

Abstract

This national multicenter study emphasizes that patient-related factors, including gender, age, baseline renal function, and liver disease severity, significantly influence the choice of first-line antiviral therapy for CHB, often outweighing disease-specific factors. Cite this article as: Yamazhan T, Zerdali E, Önlen Y, et al. A national multicenter study on initial antiviral treatment preferences on chronic hepatitis B: Entecavir versus tenofovir disoproxil fumarate. Turk J Gastroenterol. 2026;37(2):179-185.

The Turkish Journal of GastroenterologyVol. 37(2)
Sakarya University (TR), Çanakkale Onsekiz Mart Üniversitesi (TR), Izmir University (TR), Ankara University (TR), University of Turku (FI), Recep Tayyip Erdoğan University (TR), University of Health Science (KH), Ege University (TR), Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi (TR), Haseki Eğitim ve Araştırma Hastanesi (TR), Antalya Eğitim ve Araştırma Hastanesi (TR), Ümraniye Eğitim ve Araştırma Hastanesi (TR), Istanbul University-Cerrahpaşa (TR), Samsun University (TR), Sağlık Bilimleri Üniversitesi (TR), Şişli Etfal Eğitim ve Araştırma Hastanesi (TR), Mustafa Kemal University (TR), Adana Science and Technology University (TR), Istanbul University (TR), Bolu Abant İzzet Baysal University (TR), University of Health Sciences Antigua (AG)
Openalex Percentile: Top 59%
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.